Additionally, miR-122 induces the expression of de novo lipogenesis genes, including SREBP1-c, DGAT2, FAS, and ACC1, corroborating a significant physiological role of miR-122 in the biology of NAFLD. This evidence concerns the gene FAS and metabolic dysfunction-associated steatotic liver disease.